Results 91 to 100 of about 7,855 (224)

Protective Effects of Edaravone Against Hypoxia-Induced Lethality in Male Swiss Albino Mice [PDF]

open access: gold, 2020
Fatemeh Shaki   +6 more
openalex   +1 more source

Longer disease progression milestone-free time in people with amyotrophic lateral sclerosis treated versus not treated with intravenous edaravone: results from an administrative claims analysis

open access: yesJournal of Comparative Effectiveness Research
Aim: To estimate time-to-progression milestones in people with amyotrophic lateral sclerosis (PALS) treated versus not treated with intravenous (IV) edaravone (Radicava R IV, Mitsubishi Tanabe Pharma America [MTPA], hereafter ”IV edaravone”) in a real ...
James D Berry   +4 more
doaj   +1 more source

Edaravone Improved Behavioral Abnormalities, Alleviated Oxidative Stress Inflammation, and Metabolic Homeostasis Pathways in Depression [PDF]

open access: hybrid, 2023
Sina Montazeri   +5 more
openalex   +1 more source

Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats

open access: yesIranian Journal of Medical Sciences, 2017
Background: Cyclosporine A (CsA) is an immunosuppressant with therapeutic indications in various immunological diseases; however, its use is associated with chronic nephropathy. Oxidative stress has a crucial role in CsA-induced nephrotoxicity.
Elahe Sattarinezhad   +6 more
doaj  

Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats

open access: green, 2020
Hassanein EHM   +7 more
openalex   +1 more source

Neurodegenerative Evidence in Mice Brains with Cecal Ligation and Puncture-Induced Sepsis: Preventive Effect of the Free Radical Scavenger Edaravone

open access: gold, 2012
Hiroki Yokoo   +7 more
openalex   +2 more sources

Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers [PDF]

open access: gold, 2012
Hao Li   +9 more
openalex   +1 more source

Edaravone attenuates doxorubicin-induced oral mucosal injury via modulation of oxidative stress, inflammatory signaling, and the SIRT1/TLR4/NF-kB/ACE2 axis in rats. [PDF]

open access: yesBMC Oral Health
Zeytinoglu M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy